Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data? On Tuesday, Terns Pharmaceuticals Inc. (NASDAQ:TERN) shared topline 12-week results from its FALCON Phase 2 trial of TERN-601. Benzinga · Oct 22, 2025
$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall… Benzinga · Sep 9, 2022
3 Stocks Under $2 Insiders Are Aggressively Buying US crude oil futures traded higher this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment… Benzinga · Jun 9, 2022
Terns Reports Topline Results from Early-Stage NASH Study Terns Pharmaceuticals Inc (NASDAQ: TERN) Benzinga · Mar 22, 2022